Head of Investor Relations
Gilead Sciences, Inc. (GILD)Equibles does not estimate personal net worth.
Get an email with a short summary when Gilead Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get GILD alertsJackie Ross is recorded as Head of Investor Relations at Gilead Sciences, Inc. (GILD). Jackie Ross has spoken on 9 earnings calls across 1 company, most recently for Gilead Sciences, Inc. on August 4, 2026. Gilead Sciences, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Gilead Sciences, Inc. includes Daniel P. O’Day (CEO), Robin L. Washington (CFO), Diane E. Wilfong (Chief Accounting Officer) and 7 others.
“Just after market closed today, we issued a press release with earnings results for the second quarter of 2026.”
“Good afternoon, everyone, and welcome to Gilead's first quarter 2026 earnings conference call. My name is Rebecca, and I'll be today's host. In a moment, we'll begin our prepared remarks, followed by our Q&A session.”
“Just after market close today, we issued a press release with earnings results for the third quarter of 2025.”
“Just after market close today, we issued a press release with earnings results for the second quarter of 2025.”
Drug Manufacturers - General · Healthcare
Head of Investor Relations
